Immunocore Limited

Immunocore and the Bill & Melinda Gates Foundation collaborate to develop immunotherapies for infectious diseases

By Immunocore Limited
Published: Sept. 21, 2017, 2:04 p.m.· Tags: Scientific research, Research and development

$40 million investment to accelerate development of Immunocore’s ImmTAV® and ImmTAB® therapeutics for infectious diseases, in particular tuberculosis and HIV

Page 1 of 1 · Total posts: 1